| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.92B | 11.95B | 10.50B | 10.91B | 10.96B | 10.63B |
| Gross Profit | 7.49B | 5.12B | 6.17B | 6.80B | 5.50B | 4.75B |
| EBITDA | 7.09B | 7.41B | 6.57B | 7.71B | 5.70B | 5.09B |
| Net Income | 2.84B | 2.62B | 2.23B | 3.18B | 2.05B | 1.52B |
Balance Sheet | ||||||
| Total Assets | 59.57B | 58.57B | 54.53B | 52.63B | 48.43B | 47.61B |
| Cash, Cash Equivalents and Short-Term Investments | 950.00M | 63.00M | 60.00M | 2.15B | 152.00M | 1.68B |
| Total Debt | 30.30B | 29.36B | 27.08B | 26.46B | 22.90B | 23.68B |
| Total Liabilities | 44.41B | 43.58B | 39.69B | 37.74B | 34.39B | 33.51B |
| Stockholders Equity | 12.99B | 12.81B | 12.44B | 12.40B | 11.48B | 11.42B |
Cash Flow | ||||||
| Free Cash Flow | 722.00M | 1.00B | 2.40B | 3.37B | 2.61B | 2.70B |
| Operating Cash Flow | 6.07B | 5.90B | 4.97B | 5.94B | 4.89B | 3.94B |
| Investing Cash Flow | -5.19B | -5.45B | -4.86B | -3.89B | -3.38B | -1.47B |
| Financing Cash Flow | -29.00M | -442.00M | -2.20B | -49.00M | -3.04B | -942.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $66.52B | 13.83 | 13.97% | 8.04% | 12.46% | -10.48% | |
73 Outperform | $81.13B | 13.66 | 20.04% | 6.72% | -9.49% | 1.01% | |
73 Outperform | $56.31B | 11.83 | 33.27% | 7.31% | 3.18% | 6.43% | |
72 Outperform | $70.99B | 20.86 | 10.69% | 4.27% | 12.38% | 28.17% | |
70 Outperform | $89.44B | 30.75 | 22.37% | 3.35% | 9.99% | 22.02% | |
69 Neutral | $48.11B | 32.09 | 23.48% | 1.07% | 24.15% | -55.07% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |